Search Within

Ester C Dantis

Formats
  1. Journal Article (5)
  2. Meeting Abstract (4)
Groups
  1. Nursing (9)
  2. Pediatrics, Department of (4)
  3. Tow Center for Developmental Oncology (TCDO) (4)
  4. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (3)
  5. Center for Hematologic Malignancies (3)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (3)

More Groups

People
  1. Charlotte Tan (4)
  2. Kim Kramer (3)
  3. Nai-Kong Cheung (3)
  4. Ronald Finn (3)
  5. Samuel Yeh (3)
  6. Steven Larson (3)

More People

Years
  1. 2004 (1)
  2. 2001 (1)
  3. 2000 (1)
  4. 1995 (1)
  5. 1992 (1)
  6. 1987 (1)

More Years

Publications
  1. Proceedings of the American Association for Cancer Research Annual Meeting (3)
  2. Medical and Pediatric Oncology (2)
  3. Cancer Chemotherapy and Pharmacology (1)
  4. Cancer Research (1)
  5. Neuro-Oncology (1)
  6. Seminars in Oncology Nursing (1)
Publishers
  1. American Association for Cancer Research (4)
  2. Wiley Liss (2)
  3. Elsevier Inc. (1)
  4. Oxford University Press (1)
  5. Springer (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Intrathecal 131-I-labeled 3F8 antibody in patients with GD2-expressing central nervous system and leptomeningeal neoplasms
    Meeting Abstract

    Kramer, K.; Cheung, N. K. V.; Humm, J.; Yeh, S.; Dantis, E.; Dunkel, I. J.; Wolden, S.; Finn, R.; Kushner, B. H.; Khakoo, Y.; more...
    Neuro-Oncology (2004)

    Fulltext@MSK | Save
  • N7: A novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age
    Journal Article

    Cheung, N. K. V.; Kushner, B. H.; Laquaglia, M.; Kramer, K.; Gollamudi, S.; Heller, G.; Gerald, W.; Yeh, S.; Finn, R.; Larson, S. M.; more...
    Medical and Pediatric Oncology (2001)

    Fulltext@MSK | Save
  • Targeted radioimmunotherapy for leptomeningeal cancer using (131)I-3F8
    Journal Article

    Kramer, K.; Cheung, N. K. V.; Humm, J. L.; Dantis, E.; Finn, R.; Yeh, S. J.; Antunes, N. L.; Dunkel, I. J.; Souweidane, M.; Larson, S. M.
    Medical and Pediatric Oncology (2000)

    Fulltext@MSK | Save
  • Arterial, peritoneal, and intraventricular access devices
    Journal Article

    Almadrones, L.; Campana, P.; Dantis, E. C.
    Seminars in Oncology Nursing (1995)

    Fulltext@MSK | Save
  • Pharmacokinetics of ara-C and ara-U in plasma and CSF after high-dose administration of cytosine arabinoside
    Journal Article

    DeAngelis, L. M.; Kreis, W.; Chan, K.; Dantis, E.; Akerman, S.
    Cancer Chemotherapy and Pharmacology (1992)

    Fulltext@MSK | Save
  • Phase I and clinical pharmacological study of 4-demethoxydaunorubicin (idarubicin) in children with advanced cancer
    Journal Article

    Tan, C. T. C.; Hancock, C.; Steinherz, P.; Bacha, D. M.; Steinherz, L.; Luks, E.; Winick, N.; Meyers, P.; Mondora, A.; Dantis, E.; more...
    Cancer Research (1987)

    Fulltext@MSK | Save
  • Phase-I-II carboplatin (CBDCA - NSC-241240) in recurrent primary childhood brain tumors
    Meeting Abstract

    Luks, E.; Allen, J.; Walker, R.; Barfoot, S.; Dantis, E.; Tan, C.
    Proceedings of the American Association for Cancer Research Annual Meeting (1986)

    Fulltext@MSK | Save
  • Phase I study of oral idarubicin (4DMDR) in children with cancer
    Meeting Abstract

    Bacha, D.; Steinherz, L.; Dantis, E.; Mondora, A.; Tan, C.
    Proceedings of the American Association for Cancer Research Annual Meeting (1985)

    Fulltext@MSK | Save
  • Pharmacokinetics of intravenous (IV) and oral (PO) idarubicin (4DMDR) in children with cancer
    Meeting Abstract

    Hancock, C.; Bacha, D.; Niedzwiecki, D.; Dantis, E.; Tan, C.
    Proceedings of the American Association for Cancer Research Annual Meeting (1985)

    Fulltext@MSK | Save